Skip to main content
Clinical Trials/IRCT20170221032714N4
IRCT20170221032714N4
Recruiting
Phase 2

Study of the effect of Platelet Rich Fibrin (PRF) in closure of non-healing Sternum wound after open-heart Surgery

Tabriz University of Medical Sciences0 sites10 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Sternal Wound Repair.
Sponsor
Tabriz University of Medical Sciences
Enrollment
10
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • The patient has been diagnosed with an acute STEMI or NSTEMI (confirmed by segment elevation (ST) changes on serial ECG, elevated troponin, coronary artery stenosis or occlusion identified by angiography, and a wall motion abnormality identified by angiography or echocardiography); The patient is scheduled to undergo coronary artery bypass surgery;The patient does not possess any contraindication for cardiovascular magnetic resonance (CMR); The patient is capable of giving informed consent; The patient is geographically accessible and willing to return for all follow\-up investigations and clinical visits associated with study.

Exclusion Criteria

  • The Exclusion criteria of study: The patient is over the age of 65 years; The patient has previous myocardial infarction (MI) (other than the qualifying event) and/or has scar or non\-viable myocardium identified by CMR in any other left ventricular (LV) territory; The patient is undergoing other cardiac surgery (i.e. concurrent cardiac valve, or aortic surgery); The patient requires emergency surgery (i.e. operative intervention (CABG or ventricular assist device) within 24\-hrs of assessment); The patient has undergone previous cardiac surgery; The patient's post\-surgical life expectancy is less than 45 days, in the investigator's opinion; The patient is of excessively poor baseline health, health\-related quality of life, or physical functioning that would preclude a reasonable expected post\-operative recovery; The patient has received radiotherapy to the chest wall, is receiving immunosuppressive therapy, or is in any way immunocompromised.

Outcomes

Primary Outcomes

Not specified

Similar Trials